NCT07512609Recruiting
Environment, Inflammation and Metabolic Diseases Study
Source: ClinicalTrials.gov · Last updated 6 Apr 2026
Brief summary (registry, in English)
The aim is to establish an effective and practical early warning model for endocrine and metabolic diseases based on an environmental-gene-protein panoramic network, to uncover new mechanisms underlying the onset and progression of these diseases, and to screen for novel therapeutic targets.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 8000 (estimated)
- First submitted
- 20 Nov 2025
- Start date
- 25 Dec 2020
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Qifu Li
- Diseases
- High blood pressure
- NCT number
- NCT07512609
What you commit to
- Study type: Observational
- Planned participants: 8000
- From 25 Dec 2020 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Participants with incomplete data
Who the study is looking for
- All individuals who voluntarily participated in the physical examination
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Affiliated Hospital of Chongqing Medical University Coordinator of this site? Confirm its status | Chongqing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.